Taborga Jorge R. 4
4 · OMNICELL, Inc · Filed Feb 1, 2019
Insider Transaction Report
Form 4
OMNICELL, IncOMCL
Taborga Jorge R.
Executive VP. Engineering
Transactions
- Sale
Common Stock
2019-02-01$64.25/sh−786$50,498→ 36,885 total - Sale
Common Stock
2019-02-01$64.50/sh−263$16,964→ 38,999 total - Sale
Common Stock
2019-02-01$64.24/sh−645$41,435→ 37,671 total - Sale
Common Stock
2019-02-01$64.09/sh−132$8,460→ 36,753 total - Sale
Common Stock
2019-02-01$64.25/sh−683$43,881→ 38,316 total
Holdings
- 39,262
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is the average price of $64.2469. The sold price range between $64.15 to $64.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is the average price of $64.2406. The sold price range between $64.09 to $64.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is the average price of $64.2472. The sold price range between $64.00 to $64.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is the average price of $64.0882. The sold price range between $64.02 to $64.11. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.